Allianz’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Allianz's PFE Position: Q2 2026 in Review
Allianz increased its Pfizer (PFE) stake by 0.85% in Q2 2026, buying an estimated $591K and bringing the position to 2,683,370 shares worth $64.6M. The position accounts for 0.68% of the portfolio, ranked #22.
Allianz first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $74.7M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Allianz held 2,683,370 shares of Pfizer worth $64.6M as of Q2 2026.
- Allianz bought 22,589 Pfizer shares in Q2 2026, an estimated $591K.
- Pfizer made up 0.68% of Allianz's portfolio in Q2 2026, its #22 holding.
- Allianz first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
- Allianz's Pfizer position peaked at $74.7M in Q1 2026.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.